Role of host immune factors as potential biomarkers for predicting response and resistance acquisition to palbociclib-based treatment in metastatic hormono sensitive breast cancer

View all the projects

Project - Active

Role of host immune factors as potential biomarkers for predicting response and resistance acquisition to palbociclib-based treatment in metastatic hormono sensitive breast cancer

01.01.2021 - 31.12.2021

Principal Investigators: Ester Ballana Guix, Mireia Margelí
  • Participant entities: ICO, IGTP, B-ARGO
  • Strategic line: Other diseases
  • Funding entity: Pfizer

Subscribe to our newsletter

Back to Top
Irsi Caixa

Promoted by:

'La Caixa' Foundation Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Member of:

Cerca

In cooperation with: